Filter by
 

Publication date

Series/ Type

Series/type

Language

Main subject

Main subject

Keywords

Keywords

Publications database

Displaying 1 - 8 of 8

Spotlights

Spotlight on… Non-medical use of benzodiazepines

October 2021

Benzodiazepines are a widely prescribed group of medicines used to treat anxiety and insomnia and to manage alcohol withdrawal. A growing number of benzodiazepines which are not approved medicines within the European Union, such as flubromazolam or flubromazepam, have been sold at street level and...

Manuals

Non-medical use of medicines: health and social responses

October 2021

This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide 2021. The guide supports practitioners and policymakers in tackling the negative consequences of drug use. This miniguide on non-medical use of medicines provides an...

Rapid communication

New benzodiazepines in Europe – a review

June 2021

This report provides a technical review of the current body of knowledge regarding new benzodiazepines that are monitored by the EU Early Warning System. The aims of this report are to strengthen situational awareness of new benzodiazepines in Europe, and to help stakeholders prepare for and...

Technical reports

Balancing access to opioid substitution treatment (OST) with preventing the diversion of opioid substitution medications in Europe: challenges and implications

February 2021

This report reviews how opioid substitution treatment (OST) is implemented in European countries and examines the public health consequences of the diversion and misuse of prescription OST medications. It looks at how OST medications are diverted to the illicit market, the motivations behind...

Perspectives on Drugs (PODs)

The misuse of benzodiazepines among high-risk opioid users in Europe (Perspectives on drugs)

June 2018

Benzodiazepines are a widely prescribed group of medicines with a range of clinical uses, including the treatment of anxiety and insomnia and the management of alcohol withdrawal. For a number of reasons this group of medicines are often misused by high-risk opioid users and are associated with...

Perspectives on Drugs (PODs)

Strategies to prevent diversion of opioid substitution treatment medications (Perspectives on drugs)

May 2016

The use of substitution drugs for the treatment of opioid dependence represents a key evidence-based response to heroin problems in Europe. However, the diversion of these medicines from their intended use in drug treatment to non-medical use and sale on illicit drug markets is a cause for concern...

Drug profile

Benzodiazepines drug profile

May 2013

Drug profiles are scientifically sound descriptions of drugs in the form of ‘drug profiles’. Presented in a standardised way, each profile briefly gives the chemistry, pharmacology, synthesis and precursors of each substance, as well as analysis, physical form (e.g. powder, tablet) and mode of use...

Drug profile

Barbiturates drug profile

September 2011

Drug profiles are scientifically sound descriptions of drugs in the form of ‘drug profiles’. Presented in a standardised way, each profile briefly gives the chemistry, pharmacology, synthesis and precursors of each substance, as well as analysis, physical form (e.g. powder, tablet) and mode of use...
Loading